Cristin-resultat-ID: 1644902
Sist endret: 4. juli 2019 12:06
NVI-rapporteringsår: 2019
Resultat
Vitenskapelig artikkel
2019

Prescribed opioid analgesic use developments in three Nordic countries, 2006-2017

Bidragsytere:
  • Ashley Elizabeth Muller
  • Thomas Clausen
  • Per Sjøgren
  • Ingvild Odsbu og
  • Svetlana Skurtveit

Tidsskrift

Scandinavian Journal of Pain
ISSN 1877-8860
e-ISSN 1877-8879
NVI-nivå 1

Om resultatet

Vitenskapelig artikkel
Publiseringsår: 2019
Publisert online: 2019
Volum: 19
Hefte: 2
Open Access

Importkilder

Scopus-ID: 2-s2.0-85060710182

Klassifisering

Vitenskapsdisipliner

Allmennmedisin

Emneord

postoperativ smertebehandling • Opioider • Smertestillende medikamenter • Kronisk smerte

HRCS

  • Helsekategori: 20 - Generell helserelevans
    Aktivitet: 7.3 - Håndtering og beslutningstaking

Beskrivelse Beskrivelse

Tittel

Prescribed opioid analgesic use developments in three Nordic countries, 2006-2017

Sammendrag

Introduction: While the Nordic countries have considerably stricter controls on opioid prescribing for chronic non-cancer pain than other countries, previous research has warned that prescription of strong opioids is increasing. Objectives: This study examines consumption of and developments in dispensed prescribed opioids to individuals receiving ambulatory care from 2006-2017, using publicly available data from each of three Nordic countries’ national prescription registries. Methods: Repeated, cross-sectional design. One-year prevalence of all dispensed prescribed opioids in ATC N02A group were reported for Norway, Denmark, and Sweden in the period 2006-2017 by gender. One-year prevalence of the weak opioids tramadol and codeine and the strong opioid oxycodone were then reported separately over this period for each country. The mean defined daily dose (DDD) per user per year, an estimate of the amount of opioids prescribed, was reported for each of the three opioids in 2016. Results: Patterns of dispensed prescribed opioids differ greatly between 2006 and 2017 and between countries, with tramadol increasing in Norway, codeine declining across the board, and oxycodone increasing in all three countries. Norway exceeded Sweden and Denmark in prevalence of all dispensed prescribed opioids, with 12.1% of the female Norwegian population and 9.2% of the male Norwegian population dispensed at least one prescribed opioid as an outpatient in 2016. Norway’s high overall prevalence rates are tempered by dispensing the lowest mean doses of both weak opioids compared to Sweden. Similarly, Sweden dispenses the lowest mean doses of oxycodone but to the largest proportion of its population (3.0%). Conclusion: Significant shifts have occurred in the dispensing of prescribed opioids in Norway, Sweden, and Denmark over the past twelve years. The increasing prevalence of oxycodone in all three countries should continue to be monitored. Prescription registries provide a wealth of publicly available data that can be used to monitor and to guide prescribing policies in a more knowledge-based direction.

Bidragsytere

Ashley Elizabeth Muller

  • Tilknyttet:
    Forfatter
    ved Senter for rus- og avhengighetsforskning ved Universitetet i Oslo

Thomas Clausen

  • Tilknyttet:
    Forfatter
    ved Senter for rus- og avhengighetsforskning ved Universitetet i Oslo

Per Sjøgren

  • Tilknyttet:
    Forfatter
    ved Københavns Universitet
  • Tilknyttet:
    Forfatter
    ved Rigshospitalet - København Universitetshospital

Ingvild Odsbu

  • Tilknyttet:
    Forfatter
    ved Karolinska Institutet

Svetlana Skurtveit

  • Tilknyttet:
    Forfatter
    ved Avdeling for psykiske lidelser ved Folkehelseinstituttet
  • Tilknyttet:
    Forfatter
    ved Senter for rus- og avhengighetsforskning ved Universitetet i Oslo
1 - 5 av 5